Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance.
D000293:Adolescent; D000328:Adult; D002614:Chelating Agents / Q000627:therapeutic use; D002648:Child; D003300:Copper / Q000378:metabolism* / Q000652:urine; D004035:Diet Therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D004369:Pentetic Acid / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D013997:Time Factors
D002614:Chelating Agents; D003300:Copper; D004369:Pentetic Acid; D010396:Penicillamine; D011188:Potassium